ARCHIVES

UPCI Clarifies Agreement Between Eli Lilly And PCRN.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

November 5, 1993

NCI Plans $38 Million For New Research In Tobacco Control Over Next Two Years

October 16, 1998

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

NCI forms pediatric central IRB.

July 30, 2004

Coffee, Soft Drinks Have Little Association With Colon Cancer

May 28, 2010

ASSIST Gets Extra Year Of Funding While NCI Considers Role In Tobacco Control

January 17, 1997